Skip to main content
Premium Trial:

Request an Annual Quote

Your Life Will Be Unrecognizable (But in a Good Way)

Mark Wilson at Gizmodo has a Q&A with Ari Kiirikki, a VP at Knome, about what consumers can expect from the genome sequencing field in the next five to 20 years. Kiirikki says that on the shorter side of that range, the glut of new sequence data "will enable scientists to make new and important discoveries linking our DNA to health and disease, thereby further increasing the clinical utility of DNA analysis." Two decades from now, he predicts, "Every medicine you take will be tailored specifically to your genome. ... Perhaps most amazingly, your DNA will be fully integrated into your everyday life."

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.